1-8 of 8
Michael Nixon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Using Single Cell Multi-Omic Clonal Tracking in SMM to Identify Clones That Progress to MM and Harbor Treatment Resistance Features

Adam Sciambi, Daniel Mendoza, Indira Krishnan, Joanne Nguyen, Lubna Nousheen, Benjamin Geller, Cedric Dos Santos, Vivek S. Chopra, Habib Hamidi, Michael Nixon, Yann Nouet, Todd E. Druley, Herve Avet-Loiseau
Journal: Blood
Blood (2024) 144 (Supplement 1): 4722.
https://doi.org/10.1182/blood-2024-205533
Published: 2024
Journal Articles

Single Cell Multi-Omic Correlation of Single Nucleotide Variants, Copy Number Variation and Surface Epitopes for Clonal Profiling of Myeloma

Adam Sciambi, Cedric Dos Santos, Yang Li, Joanne Bio Nguyen, Priyam Priyam, Vivek Chopra, Habib Hamidi, Michael Nixon, Yann Nouet, Todd E. Druley, Herve Avet-Loiseau
Journal: Blood
Blood (2023) 142 (Supplement 1): 4714.
https://doi.org/10.1182/blood-2023-189518
Published: 2023
Journal Articles

Clinician and Patient Perspectives on Treatment Decision-Making in Multiple Myeloma: A Qualitative Survey

Nina Shah, Elizabeth S. Mearns, Sean Carey, Emily Mulvihill, Sheri A. McClerklin, Karen Thomson, Jennifer M. Ahlstrom, Allicia Girvan, R. Frank Cornell, Michael Nixon
Journal: Blood
Blood (2022) 140 (Supplement 1): 12534–12536.
https://doi.org/10.1182/blood-2022-158520
Published: 2022
Journal Articles

The Pre-Existing T Cell Landscape Is Associated with Response to High Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma

Mohammad Issam Abu Zaid, Parvathi Sudha, Travis S Johnson, Vivek S. Chopra, Cedric E. Dos Santos, Michael Nixon, Attaya Suvannasankha, Sherif S Farag, Kelvin P. Lee, Rafat Abonour, Brian A. Walker
Journal: Blood
Blood (2022) 140 (Supplement 1): 9919–9920.
https://doi.org/10.1182/blood-2022-167619
Published: 2022
Journal Articles

Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma Receiving ≥3 Lines of Therapy: A Real-World Evaluation in the United States

Allicia Girvan, Junhua Yu, Rajesh Kamalakar, Elizabeth S. Mearns, Michael Nixon, Robert F. Cornell
Journal: Blood
Blood (2022) 140 (Supplement 1): 5288–5290.
https://doi.org/10.1182/blood-2022-156225
Published: 2022
Journal Articles

Single Cell Multiomic Analysis Reveals Relapsed and Refractory Multiple Myeloma Cells Associated with 1q, TP53 , and PHF19 alterations That Affect Subclonal Chromatin Accessibility

Travis S Johnson, Parvathi Sudha, Enze Liu, Vivek S. Chopra, Cedric E. Dos Santos, Michael Nixon, Kun Huang, Rafat Abonour, Mohammad Issam Abu Zaid, Brian A. Walker
Journal: Blood
Blood (2022) 140 (Supplement 1): 598–599.
https://doi.org/10.1182/blood-2022-167301
Published: 2022
Journal Articles

Current Testing Practices for t(11;14) Rearrangements in Patients with Newly Diagnosed Multiple Myeloma in the United States

Linda B. Baughn, Elizabeth S. Mearns, Michael Nixon, Vivek S. Chopra, Allicia Girvan, R. Frank Cornell, Jayeta Saxena, Bethany M. Slifko, Jordan Clark, Shaji K Kumar
Journal: Blood
Blood (2022) 140 (Supplement 1): 10114–10115.
https://doi.org/10.1182/blood-2022-158076
Published: 2022
Journal Articles

Treatment Patterns and Outcomes of Multiple Myeloma (MM) with Chromosome Translocation (11;14) in United States (US) Routine Clinical Practice

Shebli Atrash, MD, Evelyn M. Flahavan, Tao Xu, Esprit Ma, Sudeep Karve, Wan-Jen Hong, MD, Gilbert Jirau-Lucca, Michael Nixon, Sikander Ailawadhi
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–43.
https://doi.org/10.1182/blood-2020-134703
Published: 2020